Dimopoulos M, Tedeschi A, Trotman J, et al. Multinational, randomized phase 3 trial of ibrutinib-rituximab vs placebo-rituximab with Waldenström’s macroglobulinemia. EHA 2018, abstract S852.
Vergoeding CAR T-celtherapie liso-cel (Breyanzi) bij agressief lymfoom
mei 2024 | Lymfoom